Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Protein Phosphatase 1 Inhibitor-1 Mediates the cAMP-Dependent Stimulation of the Renal NaCl Cotransporter.

Penton D, Moser S, Wengi A, Czogalla J, Rosenbaek LL, Rigendinger F, Faresse N, Martins JR, Fenton RA, Loffing-Cueni D, Loffing J.

J Am Soc Nephrol. 2019 May;30(5):737-750. doi: 10.1681/ASN.2018050540. Epub 2019 Mar 22.

PMID:
30902838
2.

Aldosterone deficiency in mice burdens respiration and accentuates diet-induced hyperinsulinemia and obesity.

Liao WH, Suendermann C, Steuer AE, Pacheco Lopez G, Odermatt A, Faresse N, Henneberg M, Langhans W.

JCI Insight. 2018 Jul 26;3(14). pii: 99015. doi: 10.1172/jci.insight.99015. eCollection 2018 Jul 26.

3.

Protein Phosphatase 1α enhances renal aldosterone signaling via mineralocorticoid receptor stabilization.

Nagarajan S, Vohra T, Loffing J, Faresse N.

Mol Cell Endocrinol. 2017 Jul 15;450:74-82. doi: 10.1016/j.mce.2017.04.020. Epub 2017 Apr 25.

PMID:
28454724
4.

Adipocyte glucocorticoid receptor has a minor contribution in adipose tissue growth.

Desarzens S, Faresse N.

J Endocrinol. 2016 Jul;230(1):1-11. doi: 10.1530/JOE-16-0121. Epub 2016 Apr 22.

PMID:
27106108
5.

Rab-GAP TBC1D4 (AS160) is dispensable for the renal control of sodium and water homeostasis but regulates GLUT4 in mouse kidney.

Di Chiara M, Glaudemans B, Loffing-Cueni D, Odermatt A, Al-Hasani H, Devuyst O, Faresse N, Loffing J.

Am J Physiol Renal Physiol. 2015 Nov 1;309(9):F779-90. doi: 10.1152/ajprenal.00139.2015. Epub 2015 Sep 2.

6.

Post-translational modifications of the mineralocorticoid receptor: How to dress the receptor according to the circumstances?

Faresse N.

J Steroid Biochem Mol Biol. 2014 Sep;143:334-42. doi: 10.1016/j.jsbmb.2014.04.015. Epub 2014 May 10. Review.

PMID:
24820770
7.

Hsp90 blockers inhibit adipocyte differentiation and fat mass accumulation.

Desarzens S, Liao WH, Mammi C, Caprio M, Faresse N.

PLoS One. 2014 Apr 4;9(4):e94127. doi: 10.1371/journal.pone.0094127. eCollection 2014.

8.

USP2-45 represses aldosterone mediated responses by decreasing mineralocorticoid receptor availability.

Faresse N, Debonneville A, Staub O.

Cell Physiol Biochem. 2013;31(2-3):462-72. doi: 10.1159/000343382. Epub 2013 Mar 19.

9.

Differential ubiquitylation of the mineralocorticoid receptor is regulated by phosphorylation.

Faresse N, Vitagliano JJ, Staub O.

FASEB J. 2012 Oct;26(10):4373-82. doi: 10.1096/fj.12-209924. Epub 2012 Jul 13.

PMID:
22798426
10.

Inducible kidney-specific Sgk1 knockout mice show a salt-losing phenotype.

Faresse N, Lagnaz D, Debonneville A, Ismailji A, Maillard M, Fejes-Toth G, Náray-Fejes-Tóth A, Staub O.

Am J Physiol Renal Physiol. 2012 Apr 15;302(8):F977-85. doi: 10.1152/ajprenal.00535.2011. Epub 2012 Feb 1.

11.

Mineralocorticoid receptor degradation is promoted by Hsp90 inhibition and the ubiquitin-protein ligase CHIP.

Faresse N, Ruffieux-Daidie D, Salamin M, Gomez-Sanchez CE, Staub O.

Am J Physiol Renal Physiol. 2010 Dec;299(6):F1462-72. doi: 10.1152/ajprenal.00285.2010. Epub 2010 Sep 22.

12.

Identification of PCTA, a TGIF antagonist that promotes PML function in TGF-beta signalling.

Faresse N, Colland F, Ferrand N, Prunier C, Bourgeade MF, Atfi A.

EMBO J. 2008 Jul 9;27(13):1804-15. doi: 10.1038/emboj.2008.109. Epub 2008 May 29.

13.

Nuclear retention of the tumor suppressor cPML by the homeodomain protein TGIF restricts TGF-beta signaling.

Seo SR, Ferrand N, Faresse N, Prunier C, Abécassis L, Pessah M, Bourgeade MF, Atfi A.

Mol Cell. 2006 Aug;23(4):547-59.

Supplemental Content

Loading ...
Support Center